Skip to main content

Pharmacotherapy in posttraumatic stress disorder: historical and clinical considerations and future directions.

Publication ,  Conference
Davidson, JR; Nemeroff, CB
Published in: Psychopharmacol Bull
1989

Posttraumatic stress disorder (PTSD) has long been recognized as responsive to drug and somatic treatments. Clinical characteristics and patterns of treatment response were well described in the 1940s. Recent studies indicate that tricyclic antidepressants and monoamine oxidase inhibitors (MAOIs) have specific ameliorative effects on PTSD symptoms, but further work is needed in this regard. Goals of drug therapy are provided and future directions suggested.

Duke Scholars

Published In

Psychopharmacol Bull

ISSN

0048-5764

Publication Date

1989

Volume

25

Issue

3

Start / End Page

422 / 425

Location

United States

Related Subject Headings

  • Stress Disorders, Post-Traumatic
  • Psychiatry
  • Humans
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Davidson, J. R., & Nemeroff, C. B. (1989). Pharmacotherapy in posttraumatic stress disorder: historical and clinical considerations and future directions. In Psychopharmacol Bull (Vol. 25, pp. 422–425). United States.
Davidson, J. R., and C. B. Nemeroff. “Pharmacotherapy in posttraumatic stress disorder: historical and clinical considerations and future directions.” In Psychopharmacol Bull, 25:422–25, 1989.
Davidson, J. R., and C. B. Nemeroff. “Pharmacotherapy in posttraumatic stress disorder: historical and clinical considerations and future directions.Psychopharmacol Bull, vol. 25, no. 3, 1989, pp. 422–25.

Published In

Psychopharmacol Bull

ISSN

0048-5764

Publication Date

1989

Volume

25

Issue

3

Start / End Page

422 / 425

Location

United States

Related Subject Headings

  • Stress Disorders, Post-Traumatic
  • Psychiatry
  • Humans